All Releases |
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Sep 6, 2007 Article in the Wall Street Journal
|
4.4 KB
|
|
Shareholders of Harris & Harris Group, Inc., may be interested to know that BridgeLux Inc., was mentioned in the September 5th issue of The Wall Street Journa. The article is entitled, "Lighting Firms Draw Investors," by Jonathan Shieber and can be found on page B3A.
Harris & Harris Group is an investor in privately held BridgeLux, In...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Sep 5, 2007 Kovio Raises $19.5 Million In New Funding Round
|
4.5 KB
|
|
Shareholders of Harris & Harris Group, Inc., may be interested to know that Kovio, Inc., announced today that it has raised $19.5 million in the first closing of its Series D funding round. The round was led by Pinnacle Ventures and also included investments from Bessemer Venture Partners, Duff Ackerman & Goodrich Ventures, DEA capital, Flags...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Sep 4, 2007 Ensemble Discovery Names New President And CEO
|
4.4 KB
|
|
Shareholders of Harris & Harris Group, Inc., may be interested to know that Michael D. Taylor, Ph.D., has been named President and Chief Executive Officer of Ensemble Discovery Corporation. The full press release can be read at www.ensemblediscovery.com
Harris & Harris Group is an investor in privately held Ensemble Discovery Corpor...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 28, 2007 Founder Of Ancora Wins Korber Prize
|
4.4 KB
|
|
Shareholders of Harris & Harris Group, Inc., may be interested to know that Peter Seeberger, founder of Ancora Pharmaceuticals, has been awarded the 2007 Korber Prize for Science. The prestigious German science award recognizes European scientists for applied and pioneering research.
Harris & Harris Group is an investor in privately...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 15, 2007 Nanosphere, Inc., Files For IPO
|
4.4 KB
|
|
Shareholders of Harris & Harris Group, Inc., may be interested to note that Nanosphere, Inc., filed a Registration Statement on Form S-1 on August 13, 2007. The lead underwriter of the proposed offering is Credit Suisse. The filing may be accessed at http://www.sec.gov. Harris & Harris Group is not an investor in Nanosphere.
Harris ...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 9, 2007 Harris & Harris Group Shareholder Report on Website
|
4.6 KB
|
|
NEW YORK, Aug 09, 2007 (BUSINESS WIRE) -- Shareholders of Harris & Harris Group, Inc., may be interested to know that we have posted our Shareholder Report for the second quarter of 2007 on our website. It may be accessed directly on our website at http://www.tinytechvc.com/newsite/PDFs/q22007.pdf.
Harris & Harris Group is a publicly traded ven...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 8, 2007 Harris & Harris Group Reports Financial Statements as of June 30, 2007
|
4.9 KB
|
|
NEW YORK, Aug 08, 2007 (BUSINESS WIRE) -- Harris & Harris Group, Inc., reported today that, as of June 30, 2007, its net asset value and net asset value per share were $128,222,333 and $5.54, respectively.
SUMMARY OF FINANCIAL RESULTS
----------------------------------------------------------------------
...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 7, 2007 Harris & Harris Group Notes BridgeLux Financing Closing
|
4.7 KB
|
|
NEW YORK, Aug 07, 2007 (BUSINESS WIRE) -- Shareholders of Harris & Harris Group, Inc., may be interested to know that BridgeLux, Inc., has announced the closing of a $23 million Series C round of financing. Harris & Harris Group invested $916,928 in this round. BridgeLux is a leading supplier of energy-saving LED technology to high-volume solid sta...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 7, 2007 Portfolio Company's CEO Is Interviewed By Red Herring.TV
|
4.5 KB
|
|
Shareholders of Harris & Harris Group may be interested to listen to an interview of Conrad Burke, Chief Executive Officer of Innovalight, Inc., by Sean Wolfe of RedHerring.TV. The interview, posted on August 6, 2007, may be accessed at http://www.redherring.tv/innovalight.htm. In May 2007, Innovalight won one of the Red Herring 100 Awards. ...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Aug 1, 2007 NASDAQ's Portal Market Trading System Approved By SEC
|
4.5 KB
|
|
Shareholders of Harris & Harris Group may be interested to read the press release issued by Nasdaq Stock Market about its Electronic Trading Platform for the 144A private placement market (http://www.nasdaq.com/newsroom/news/newsroomnewsStory.aspx? textpath=pr2007\ACQPMZ200708010800PRIMZONEFULLFEED124065.htm&cdtime;=08%2f01%2f2007%20+8%3a00AM. )...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jul 30, 2007 Ensemble Discovery Collaborates With Roche
|
4.6 KB
|
|
Shareholders of Harris & Harris Group may be interested to know that Ensemble Discovery Corporation announced the initiation of a collaboration with Roche of Basel, Switzerland to apply Ensemble's proprietary diagnostic technology to the optimization of selection of cancer therapy. The collaboration will apply this technology to analyze combi...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jul 25, 2007 Innovalight Collaborates With U.S. Department Of Energy's National Renewable Energy Laboratory
|
4.4 KB
|
|
Shareholders of Harris & Harris Group may be interested to read the article, "Unique Quantum Effect Found in Silicon Nanocrystals," which can be found at http://physorg.com/news104511242.html.
Harris & Harris Group is an investor in privately held Innovalight, Inc.
Harris & Harris Group is a publicly traded venture capital...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jul 17, 2007 Article In The New York Times
|
4.5 KB
|
|
Shareholders of Harris & Harris Group may be interested to read the article on page F-2 of today's New York Times entitled, "Using the 'Beauties of Physics' to Conquer Science Illiteracy," by Claudia Dreifus, in which she interviews Professor Eric Mazur of Harvard. The "black silicon" invention to which Dr. Mazur alludes in the interview is t...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jul 11, 2007 Starfire Systems Receives $10 Million Commitment From Palladium Equity Partners
|
4.5 KB
|
|
Shareholders of Harris & Harris Group may be interested to know that Palladium Equity Partners, LLC, has committed to invest up to $10 million in Starfire Systems through the acquisition of preferred stock in a private placement. Starfire Systems is a developer and manufacturer of nanostructured advanced ceramic materials and finished product...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jul 10, 2007 Article In The Journal Of New England Technology
|
4.4 KB
|
|
(Shareholders of Harris & Harris Group may be interested to read an article (http://masshightech.bizjournals.com/masshightech/stories/2007/07/09/story7.html) in the July 6, 2007, Journal of New England Technology by Ryan McBridge entitled, "Ancora Anchors Drug Plans with $2.2M in VC."
Harris & Harris Group is an investor in privately...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jun 21, 2007 Article In The New York Times
|
4.4 KB
|
|
Shareholders of Harris & Harris Group may be interested to read an article in today's New York Times on page C10 entitled, "New Rules Expected on Safety of Nanotechnology Products," by Barnaby J. Feder.
Harris & Harris Group is a publicly traded venture capital company that makes initial investments exclusively in tiny technology, in...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jun 15, 2007 Harris & Harris Group Announces 1.3 Million Share Common Stock Placement with Institutional Investors
|
5.7 KB
|
|
NEW YORK, Jun 15, 2007 (BUSINESS WIRE) -- Harris & Harris Group, Inc., announced today that it has entered into definitive agreements with institutional investors to sell 1.3 million shares of its common stock at a price of $10.79 per share through a registered offering for net proceeds, after placement agent fees and estimated offering expenses, o...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jun 15, 2007 Harris & Harris Group Reports Net Asset Value
|
5.2 KB
|
|
NEW YORK, Jun 15, 2007 (BUSINESS WIRE) -- In connection with a proposed public offering of shares of common stock directly to institutional investors pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission, we have determined that our net asset value per share as of June 14, 2007, was $5.28.
This ...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jun 7, 2007 Solazyme And Imperium Renewables Enter Into Development Agreement
|
4.4 KB
|
|
Shareholders of Harris & Harris Group, Inc., may wish to read on http://www.solazyme.com/news070606.shtml the announcement dated June 6, 2007, regarding Solazyme's development agreement with Imperium Renewables. Harris & Harris Group is an investor in privately held Solazyme.
Harris & Harris Group is a publicly traded venture capi...
|
Read more
|
![View Summary View Summary](../common/images/ir_subdomain/directory_plus.gif)
|
Jun 6, 2007 Mersana Initiates Phase I Trial
|
4.5 KB
|
|
Shareholders of Harris & Harris Group, Inc., may wish to read on www.mersana.com the announcement dated May 30, 2007, regarding the initiation of a Phase I open-label, dose-escalation trial of its lead product candidate, XMT-1001, in patients with solid tumors. Harris & Harris Group was the first institutional investor in Mersana Therapeutics...
|
Read more
|
|